SCHEMBL2411279

SCHEMBL2411279

COc1ccc[c]c1Cc1ccc(C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.38
HTR1A P08908 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 4/20 0.35
MAPT P10636 2/20 0.35
ATM Q13315 1/20 0.35
CA2 P00918 2/20 0.35
MAOB P27338 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
LTA4H P09960 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HTR7 P34969 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413817 0.87 KMT2A (0.38) MAPTCA2MAOBSMN1; SMN2MAPK1
SCHEMBL8859963 0.86 LTA4H (0.44) HTR1AADRA1DADRA1AADRA1BCA2
SCHEMBL9978976 0.77 IDO1 (0.34) LMNAMAPTSMN1; SMN2TSHRMAPK1
SCHEMBL4917488 0.76 IDO1 (0.46) LMNAL3MBTL1MAPTATMCA2
SCHEMBL64882 0.74 CA1 (0.42) LMNAL3MBTL1MAPTCA2CA12
SCHEMBL18706055 0.74 HTR7 (0.42) HTR1AMAPTCA2CA12CA1
SCHEMBL1526352 0.73 CA1 (0.41) LMNAL3MBTL1MAPTCA2CA12
SCHEMBL4586248 0.73 TAAR1 (0.41) LMNAMAPTCA2CA12CA1
SCHEMBL28069112 0.73 CA1 (0.41) LMNAL3MBTL1MAPTCA2CA12
SCHEMBL6203845 0.73 CA1 (0.41) LMNAL3MBTL1MAPTCA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828107-B1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE SANOFI AVENTIS DEUTSCHLAND (DE) 2011-09-28 EP disclosed
US-7453009-B2 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-11-18 US disclosed
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE GPR119, HACL2, HCAR2 LMNA 3244/4885HTR1A 2121/4885ADRA1D 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.